Chikao Morimoto

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Binding Protein

Transcription Factor

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroko Nishida, Reiko Suzuki, Kiyora Nakajima, Mutsumi Hayashi, Chikao Morimoto, Taketo Yamada
HDAC Inhibition Induces CD26 Expression on Multiple Myeloma Cells via the c-Myc/Sp1-mediated Promoter Activation. Cancer research communications 4 (2) (2024)
Hiroko Nishida, Reiko Suzuki, Kiyora Nakajima, Mutsumi Hayashi, Chikao Morimoto, Taketo Yamada
HDAC inhibition induces CD26 expression on myeloma cells via the c-Myc/Sp1-mediated promoter activation. Cancer research communications (2024)
Hiroko Nishida, Reiko Suzuki, Kiyora Nakajima, Mutsumi Hayashi, Chikao Morimoto, Taketo Yamada
HDAC Inhibition Induces CD26 Expression on Multiple Myeloma Cells via the c-Myc/Sp1-mediated Promoter Activation. Cancer research communications 4 (2) (2024)
Ryo Hatano, Takumi Itoh, Haruna Otsuka, Sayo Okamoto, Eriko Komiya, Satoshi Iwata, Thomas M Aune, Nam H Dang, Kyoko Kuwahara-Arai, Kei Ohnuma, Chikao Morimoto
Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis. mAbs 11 (8) (2019)
Ryo Hatano, Taketo Yamada, Hiroko Madokoro, Haruna Otsuka, Eriko Komiya, Takumi Itoh, Yuka Narita, Satoshi Iwata, Hiroto Yamazaki, Shuji Matsuoka, Nam H Dang, Kei Ohnuma, Chikao Morimoto
Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens. PloS one 14 (6) (2019)